Mesenchymal stem cells-like as a prognostic biomarker in patients diagnosed with acute myeloid leukemia.

Sci Rep · 2025 · PMC12663226 · PMID 41315789

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significanceP < 0.057so close (0.05 < p ≤ 0.1)

Adverse ELN 2017 risk was also associated with worse OS (HR = 15.78; 95% CI 3.36–74.15; P < 0.001), whereas the intermediate-risk category did not reach statistical significance (HR = 4.28; 95% CI 0.96–19.1; P < 0.057) (global P for the variable < 0.001).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.